Prosight Management’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-240,000
| Closed | -$1.89M | – | 41 |
|
|
2023
Q1 | $1.89M | Sell |
240,000
-381,667
| -61% | -$3M | 0.89% | 29 |
|
|
2022
Q4 | $4.2M | Buy |
621,667
+91,605
| +17% | +$619K | 2.29% | 17 |
|
|
2022
Q3 | $7.69M | Sell |
530,062
-290,690
| -35% | -$4.22M | 4.12% | 8 |
|
|
2022
Q2 | $8.08M | Buy |
820,752
+231,482
| +39% | +$2.28M | 6.36% | 5 |
|
|
2022
Q1 | $8.69M | Buy |
589,270
+179,650
| +44% | +$2.65M | 5.61% | 5 |
|
|
2021
Q4 | $5.42M | Buy |
409,620
+152,229
| +59% | +$2.01M | 3.24% | 11 |
|
|
2021
Q3 | $4.49M | Buy |
257,391
+76,220
| +42% | +$1.33M | 2.47% | 12 |
|
|
2021
Q2 | $4.34M | Buy |
+181,171
| New | +$4.34M | 2.71% | 15 |
|